N	Concordance
1	with recurrent or progressive low grade lymphoma. We report here on the toxicity
2	nts included 31 patients with low grade lymphoma, 55 with intermediate or high g
3	n the evolutive course of the low grade lymphoma. The natural history of a low g
4	 ents with advanced stages of low-grade lymphoma are not cured with current ther
5	 important prognostic tool in low-grade lymphoma and may be used in the selectio
6	rade lymphomas; however, like low-grade lymphoma, aggressive combination chemoth
7	ult in complete regression of low-grade lymphoma of the gastric mucosa-associate
8	gressive lymphomas useful for low-grade lymphoma patients? Applicability to stag
9	1% and usually > 29%). In the low-grade lymphoma group, a macronucleolated mediu
10	 50%, and those with relapsed low-grade lymphoma had a response rate of 31%. In 
11	isseminated (stage III or IV) low-grade lymphoma were enrolled in a prospective